Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

XDx brings in $26.5mm with Series E round

Executive Summary

Molecular diagnostics company XDx has completed its Series E financing round, bringing in $26.5mm. Led by Duff Ackerman & Goodrich, additional investors included Intel Capital and existing backers Kleiner Perkins Caufield & Byers, Texas Pacific Group Ventures, Sprout Group (managed by New Leaf Venture Partners), Burrill & Co., Integral Capital, and Bay Area Equity Fund (managed by JP Morgan).
Deal Industry
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies